Beneficial effects of the melanocortin α-melanocyte-stimulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury

Neurosurgery

Volumn 40, Issue 1, 1997, Pages 122-131

  Van De Meent, Hendrik ^a   Hamers, Frank P T ^a   Lankhorst, Alex J ^a   Joosten, Elbert A J ^b   Gispen, Willem H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Evoked; Melanocortins; Neurological recovery; potentials; Rat; Spinal cord injury

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; MELANOCORTIN; METHYLPREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; LOCOMOTION; MALE; NERVE FIBER GROWTH; NEUROPHYSIOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REMYELINIZATION; SPINAL CORD FUNCTION; SPINAL CORD INJURY; WHITE MATTER;

ALPHA-MSH; ANIMALS; EVOKED POTENTIALS, MOTOR; MALE; METHYLPREDNISOLONE; NERVE REGENERATION; NEUROLOGIC EXAMINATION; RATS; RATS, WISTAR; SPINAL CORD; SPINAL CORD INJURIES;

EID: 0031032740     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199701000-00028     Document Type: Article

References (69)

1. Adan RAH, Van der Kraan M, Doornbos RP, Bär PR, Burbach JPH, Gispen WH: Melanocortin receptors mediate α-MSH-induced Stimulation of neunte outgrowth in Neuro 2A cells. Mol Brain Res 36:37-44, 1996.
2. Allen AR: Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. JAMA 57:878-880, 1911.
3. Anderson DK, Hall ED, Braughler JM, McCall JM, Means ED: Effect of delayed administration of U74006F (tirilazad mesylate) on recovery of locomotor function after experimental spinal cord injury. J Neurotrauma 8:187-192, 1991.
4. Bakshi R, Faden AI: Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis. Brain Res 507:1-5, 1990.
5. Behrmann DL, Bresnahan JC, Beattie MS: A comparison of YM-14673, U-50488H, and nalmefene after spinal cord injury in the rat. Exp Neurol 119:258-267, 1993.
6. Bijlsma WA, Jennekens FGI, Schotman P, Gispen WH: Stimulation by ACTH(4-10) on nerve fiber regeneration following sciatic nerve crush. Muscle Nerve 6:104-112, 1983.
7. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, Marshall LF, Perot PL Jr, Piepmeier J, Sonntag VKH, Wagner FC, Wilberger JE, Winn HR: A randomized, controlled trial of merhylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322:1405-1411, 1990.
8. Braughler JM, Hall ED: Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J Neurosurg 61: 290-295, 1984.
9. Braughler JM, Hall ED, Means ED, Waters TR, Anderson DK: Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. J Neurosurg 67:102-105, 1987.
10. Catania A, Lipton JM: α-Melanocyte-stimulating hormone in the modulation of host reactions. Endocr Rev 14:564-576, 1993.
11. Chhajlani V, Muceniece R, Wikberg JES: Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 195:866-873, 1993.
12. Collins WF: A review and update of experimental and clinical studies of spinal cord injury. Paraplegia 21:204-219, 1983.
13. Constantini S, Young W: The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J Neurosurg 80:97-111, 1994.
14. 4-9, analogue Org 2766: Different routes of administration. Peptides 8:1057-1059, 1987.
15. De Koning P, Neijt JP, Jennekens FGI, Gispen WH: ORG 2766 protects from cisplatin-induced neurotoxicity in rats. Exp Neurol 97:746-750, 1988.
16. De la Torre JC: Spinal cord injury: Review of basic and applied research. Spine 6:315-335, 1981.
17. Dohrmann GJ, Panjabi MM, Wagner FC: An apparatus for quanritaring experimental spinal cord trauma. Surg Neurol 5:315-318, 1976.
18. Duckers HJ, Dokkum RP, Verhaagen J, Lopes da Silva FH, Gispen WH: Functional and neurophysiological evidence of the efficacy of trophic repair pharmacotherapy in CEAE, an animal model of multiple sclerosis. J Neurosci (in press).
19. Duckers HJ, Verhaagen J, de Bruijn E, Gispen WH: Effective use of a neurotrophic ACTH4-9 analogue in the treatment of a peripheral demyelinating syndrome (experimental allergic neuritis): An intervention study. Brain 117:365-374, 1994.
20. Edwards PM, Van der Zee CEEM, Verhaagen J, Schotman P, Jennekens FGI, Gispen WH: Evidence that the neurotrophic action of αMSH may derive from its ability to mimic the actions of a peptide formed in degenerating nerve stumps. J Neurol Sci 64:333-340, 1984.
21. Faden AI, Lemke M, Demediuk P: Effects of BW755C, a mixed cyclo-oxygenase-lipoxygenase inhibitor, following traumatic spinal cord injury in rats. Brain Res 463:63-68, 1988.
22. Fehlings MG, Tator CH, Linden RD: The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J Neurosurg 71:403-416, 1989.
23. Feringa ER, Kinning WK, Britten AG, Vahlsing HL: Recovery in rats after spinal cord injury. J Neurology 26:839-843, 1976.
24. Ford RWJ: A reproducible spinal cord injury model in the cat. J Neurosurg 59:268-275, 1983.
25. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T: Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268: 15174-15179, 1993.
26. Gantz I, Shimoto Y, Konda Y, Miwa H, Dickinson CJ, Yamada T: Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 200:1214-1220, 1994.
27. Geisler FH, Dorsey FC, Coleman WP: Recovery of motor function after spinal-cord injury, a randomized placebo-controlled trial with GM-1 ganglioside. N Engl J Med 324:1829-1838, 1991.
28. Gispen WH, Verhaagen J, Bär PR: ACTH/MSH-derived peptides and peripheral nerve plasticity: Neuropathies, neuroprotection and repair. Prog Brain Res 100:223-233, 1994.
29. Griffiths IR, McCulloch MC: Nerve fibres in spinal cord impact injuries: Part 1 - Changes in the myelin sheath during the initial 5 weeks. J Neurol Sci 58:335-349, 1983.
30. Hall ED: Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury. Cell Mol Neurobiol 13:415-432, 1993.
31. +)-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat. J Neurosurg 57:247-253, 1982.
32. Hall ED, Wolf DL, Braughler JM: Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia: Dose-response and time-action analysis. J Neurosurg 61:124-130, 1984.
33. Hamers FP, Pette C, Bravenboer B, Vecht CJ, Neijt JP, Gispen WH: Cisplatin-induced neuropathy in mature rats: Effects of the melanocortin-derived peptide ORG 2766. Cancer Chemother Pharmacol 32:162-166, 1993.
34. Hamers FP, Pette C, Neijt JP, Gispen WH: The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats. Eur J Pharmacol 233:177-178, 1993.
35. Hannigan JH Jr, lsaacson RL: The effects of ORG 2766 on the performance of sham, neocortical, and hippocampal-lesioned rats in a food search task. Pharmacol Biochem Behav 23:1019-1027, 1985.
36. Hol EM, Hermens WT, Verhaagen J, Gispen WH, Bar PR: αMSH but not Org 2766 induces expression of c-fos in cultured rat spinal cord cells. Neuroreport 4:651-654, 1993.
37. 14C-iodoantipyrine autoradiography during and after graded spinal cord compression in rats. Surg Neurol 31:350-360, 1989.
38. Holtz A, Nystrom B, Gerdin B: Effect of methylprednisolone on motor function and spinal cord blood flow after spinal cord compression in rats. Acta Neurol Scand 82:68-73, 1990.
39. Hung TK, Lin HS, Albin MS, Bunegin L, Jannetta PJ: The standardization of experimental impact injury to the spinal cord. Surg Neurol 11:470-477, 1979.
40. Isaacson RL: An ACTH sub(4-9) analog (ORG 2766) speeds recovery from septal hypermotionality in the rat. Behav Neural Biol 39:52-59, 1983.
41. Joosten EAJ, Van de Meent H, Bär PR, Gispen WH: Melanocortins stimulate neurite outgrowth in the injured adult rat spinal cord. J Neurotrauma 12:373, 1995 (abstr).
42. Kakulas BA: The clinical neuropathology of spinal cord injury, a guide to the future. Paraplegia 25:212-216, 1987.
43. Koenig G, Dohrmann GJ: Histopathological variability in "standardised" spinal cord trauma. J Neurol 40:1203-1210, 1977.
44. Means ED, Anderson DK, Waters TR, Kalaf L: Effect of methylprednisolone in compression trauma to the feline spinal cord. J Neurosurg 55:200-208, 1981.
45. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD: Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298-1308, 1994.
46. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD: The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248-1251, 1992.
47. Noble LJ, Wrathall JR: Spinal cord contusion in the rat: Morphometric analysis of alterations in the spinal cord. Exp Neurol 88:135-149, 1985.
48. Noble LJ, Wrathall JR: An inexpensive apparatus for producing graded spinal cord contusive injury in the rat. Exp Neurol 95: 530-533, 1987.
49. Nyakas C, Veldhuis HD, De Wied D: Beneficial effect of chronic treatment with Org 2766 and αMSH on impaired reversal learning of rats with bilateral lesions of the parafascicular area. Brain Res Bull 15:257-265, 1985.
50. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. San Diego, Academic Press, 1986.
51. Pitsikas N, Spruijt BM, Josephy M, Algeri S, Gispen WH: Effect of Org2766, an ACTH(4-9) analogue, on recovery after bilateral transection of the fimbria fornix in the rat. Pharmacol Biochem Behav 38:931-934, 1991.
52. Sandler AN, Tator CH: Review of the effect of spinal cord trauma on the vessels and blood flow in the spinal cord. J Neurosurg 45:638-646, 1976.
53. Strand FL, Rose KJ, Zuccarelli LA, Kume J, Alves SE, Antonawich FJ, Garrett LY: Neuropeptide hormones as neurotrophic factors. Physiol Rev 71:1017-1046, 1991.
54. Strand FL, Williams KA, Alves SE, Antonawich FJ, Lee TS, Lee SJ, Kume J, Zuccarelli LA: Melanocortins as factors in somatic neuromuscular growth and regrowth. Pharmacol Ther 62:1-27, 1994.
55. Tarlov IM: Spinal cord compression studies: III - Time limits for recovery after gradual compression in dogs. Arch Neurol Psychiatry 71:588-597, 1954.
56. Tator CH, Fehlings MG: Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75:15-26, 1991.
57. Ulenkate HJ, Verhagen MA, Gispen WH, Jennekens FG: The neurotrophic analogue of ACTH(4-9) reduces the perineuronal microglial reaction after rat facial nerve crush. Glia 9:219-226, 1993.
58. Van de Meent H, Hamers FPT, Joosten EAJ, Gispen WH: Objective assessment of spinal cord function after contusive spinal cord injury in the rat. Eur J Neurosci 8[Suppl]:197, 1995 (abstr).
59. Van de Meent H, Hamers FPT, Lankhorst AJ, Joosten EAJ, Gispen WH: New assessment techniques for evaluation of posttraumatic spinal cord function in rat. J Neurotrauma (in press).
60. Van der Hoop RG, Vecht CJ, Van der Burg ME, Elderson A, Boogerd W, Vries EP, Van Houwelingen JC, Jennekens FG, Gispen WH: Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue inpatients with ovarian cancer. N Engl J Med 322:89-94, 1990.
61. Van der Neut R, Hol EM, Gispen WH, Bar PR: Stimulation by melanocortins of neurite outgrowth from spinal and sensory neurons in vitro. Peptides 13:1109-1115, 1992.
62. Van der Zee CEEM, Brakkee JH, Gispen WH: αMSH and Org.2766 in peripheral nerve regeneration: Different routes of delivery. Eur J Pharmacol 147:351-357, 1988.
63. Van Ree JM, Wolterink G, Vos JP, Steinbusch HWM: The ACTH(4-9) analog ORG 2766 and postlesion plasticity in the brain. Eur Neuropsychopharmacology 1:386-388, 1991.
64. Verhaagen J, Edwards PM, Jennekens FGI, Gispen WH: Pharmacological aspects of the influence of melanocortins on the formation of regenerative peripheral nerve sprouts. Peptides 8:581-584, 1987.
65. Verhaagen J, Edwards PM, Jennekens FGI, Schotman P, Gispen WH: α-Melanocyte-stimulating hormone stimulates the outgrowth of myelinated fibers after peripheral nerve crush. Exp Neurol 92:451-454, 1986.
66. Wolterink G, Van Ree JM: Functional recovery after destruction of dopamine systems in the nucleus accumbens of rats: III - Further analysis of the facilitating effect of the ACTH-(4-9) analog ORG 2766. Brain Res 507:109-114, 1990.
67. Wolterink G, Van Zanten E, Van Ree JM: Functional recovery after destruction of dopamine systems in the nucleus accumbens of rats: IV - Delay by intra-accumbal treatment with ORG 2766- or α-MSH antiserum. Brain Res 507:115-120, 1990.
68. Wrathall JR, Pettegrew RK, Harvey F: Spinal cord contusion in the rat: Production of graded, reproducible, injury groups. Exp Neurol 88:108-122, 1988.
69. Young W, Flamm ES: Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury. J Neurosurg 57:667-673, 1982.